KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nov (NOV) EBITDA (2016 - 2025)

Nov (NOV) has disclosed EBITDA for 17 consecutive years, with -$323.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 34.62% to -$323.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.0 million through Dec 2025, down 54.86% year-over-year, with the annual reading at $79.0 million for FY2025, 54.86% down from the prior year.
  • EBITDA hit -$323.0 million in Q4 2025 for Nov, down from $107.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $313.0 million in Q2 2024 to a low of -$494.0 million in Q4 2024.
  • Historically, EBITDA has averaged $51.8 million across 5 years, with a median of $116.5 million in 2023.
  • Biggest five-year swings in EBITDA: skyrocketed 1180.0% in 2022 and later crashed 406.83% in 2024.
  • Year by year, EBITDA stood at -$15.0 million in 2021, then surged by 1180.0% to $162.0 million in 2022, then dropped by 0.62% to $161.0 million in 2023, then plummeted by 406.83% to -$494.0 million in 2024, then skyrocketed by 34.62% to -$323.0 million in 2025.
  • Business Quant data shows EBITDA for NOV at -$323.0 million in Q4 2025, $107.0 million in Q3 2025, and $143.0 million in Q2 2025.